In a previous issue of Critical Care, Krinsley and colleagues [1] report fi ndings consistent with those of other investigators, namely that moderate hypoglycemia occurring in patients treated in intensive care units (ICUs) is associated with an increased risk of death. Th at hypoglycemia is associated with an increased risk of death is not necessarily news; it is a consistent fi nding in diff erent populations, including patients treated in ICUs [2, 3] and type II diabetes patients recruited to large randomized controlled trials [4, 5] . Th e authors' report replicates those research fi ndings but also highlights the complexity of unraveling association from causation and the importance of using the correct methodology when analyzing such data.
Krinsley and colleagues report on a cohort of patients drawn from a hospital in the US, patients from three hospitals in Th e Netherlands, and patients recruited to the Glucontrol Study [6] . Although it is clear that hypoglycemia is associated with an increased risk of death, a causal relationship has not been established. As with any observed physiological abnormality, the occurrence of hypoglycemia may be a marker of disease severity and so merely indicate that a patient is sick and at increased risk of dying or it may be truly harmful and act independently to increase the risk of death. Is it possible to tease out the role of hypoglycemia in the mortality of critically ill patients, and does the report by Krinsley and colleagues help us to do so?
In 1965, Sir Austin Bradford Hill [7] elucidated nine characteristics that help establish a causal relationship between exposure to a potentially harmful substance or event and disease onset or death: (a) the strength of the association, (b) its consistency, (c) its specifi city (is it associated with death from a specifi c cause?), (d) its temporal relationship, (e) its biological gradient (is there a dose-response relationship?), (f ) its plausibility, (g) coherence (the hypothesis does not confl ict with the known natural history of the disease), (h) experiment (if other factors are kept equal, does preventing exposure reduce the risk of death?), and (i) analogy (does manipulating factors that are similarly associated with an increased risk of death im prove outcome?). Applying Hill's criteria we can conclude that the association between hypoglycemia and death, though not overly strong, is consistent, and there is evidence of a doseresponse relationship [2] . It is plausible given that hypoglycemia has many known adverse physiological eff ects [8] [9] [10] , and the hypothesis does not confl ict with our current view of the natural history of critical illness. Where we run into trouble is in the areas of the temporal nature of the relationship, its specifi city, and analogy.
To establish the temporal relationship, we must demon strate that hypoglycemia occurring in patients who were not already dying increases the subsequent risk of death; this is very diffi cult to do. For example, it is clear that hypoglycemia occurs in patients with acute hepatic necrosis and that hypoglycemia is a marker of a severe disease that is killing a patient but hypoglycemia is not the cause of death. Such gross examples are relatively Abstract Hypoglycemia is consistently associated with an increased risk of death in hospital patients in general, patients treated in intensive care units, and type II diabetes patients recruited to large randomized controlled trials. In 1965, Sir Austin Bradford Hill elucidated nine characteristics that help establish a causal relationship between exposure to a potentially harmful substance or event (in this context, hypoglycemia) and disease onset or death; hypoglycemia exhibits some of those characteristics but others remain to be explored. While we await data that address the outstanding issues, common sense dictates that clinicians avoid causing hypoglycemia whenever possible.
easy to identify, and such patients can be removed from analysis; what we do not know is whether more subtle examples of the same phenomenon are contaminating the remaining data.
Specifi city refers to an association that is present only, or at least more strongly, for death from a certain specifi c cause. For example, cigarette smoking is more strongly associated with death from lung cancer than death from other causes. Few ICU databases or clinical trials record cause-specifi c mortality and so the specifi city of the relationship is currently unclear. Th e NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) investigators did report cause-specifi c mortality [11] ; it is possible that a careful analysis of that data could prove useful. If we were able to exclude patients whose hypoglycemia was indicative of their dying from another cause and if we found a strong association with a specifi c cause of death, we would still have the problem of knowing whether hypo gly cemia is harmful per se or indicative of some other glucose control feature that is harmful. Th e most likely candidate might be glucose variability, which is also independently associated with an increased risk of death [12, 13] .
Analogy refers to the idea that a causal relationship is more likely if similar associations have been clearly established as causal. Candidates in this context include hyperglycemia (which can be expressed in a number of ways but, to date, has been expressed mostly as mean blood glucose) and blood glucose variability given that both are strongly associated with an increased risk of death. To date, trials of lowering mean blood glucose have not improved outcome [14] and a causal relationship is not established for glucose variability. A further complication is the possibility that hypoglycemia itself may not be harmful but that the harm comes instead from rapid correction of hypoglycemia leading to rebound hyperglycemia [15] .
So where does that leave us? It is clear that even moderate hypoglycemia is associated with an increased risk of death, but a causal relationship is not, and perhaps cannot be, fi rmly established. While the association with an increased risk of death is clear, it is entirely possible that hypoglycemia has important but less apparent longterm eff ects in survivors; an obvious concern would be neurological injury that might be apparent only with careful neuropsychiatric testing.
Future research can contribute to our knowledge by reporting cause-specifi c mortality, by analyzing timedependent variables up to and following episodes of hypo glycemia to clearly establish the temporal relationship, and by determining whether the impact of hypoglycemia is independent of other indices of glucose control. In the meantime, it is hard to argue with the commonsense conclusion that clinicians should seek to avoid hypoglycemia, defi ned as a blood glucose concentration of 3.9 mmol/L (70 mg/dL) or less [16] , wherever possible in critically ill patients. Abbreviation ICU, intensive care unit.
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